Accessibility Menu
Merck KGaA logo

Merck KGaA(OTC) MKGAF

Market Cap$70.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+492%
5 Year-24%
1 Year+26%
1 Month+6%
$163.21
+0.67%
+1.09Today
Merck KGaA last closing stock price
MetricPriceDate
Last closeUSD 163.212026-08-21
Merck KGaA stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.91%USD 158.602026-08-14
1 month+5.93%USD 154.082026-07-22
3 month+7.84%USD 151.342026-05-22
Year to date+12.8%USD 144.692025-12-31
1 year+25.58%USD 129.962025-08-21
3 year+1.49%USD 160.812023-08-22
5 year-23.97%USD 214.652021-08-19
Since inception+492.3%USD 27.562003-06-25

Merck KGaA Financials at a Glance

Market Cap

$70.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€21.14B

Net Income (TTM)

€2.37B

EPS (TTM)

$6.36

P/E Ratio

25.65

Dividend

$2.58

Beta (Volatility)

0.48 (Low)

Price

$163.21

Volume

561

Open

$163.47

Previous Close

$163.21

Daily Range

$156.48 - $166.23

52-Week Range

$116.68 - $175.56

Estimated Earnings Date

Nov 12, 2026

MKGAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Merck KGaA

Merck KGaA is a prominent science and technology company based in Darmstadt, Germany, established in 1668. The company operates through three main divisions: Life Science, Healthcare, and Electronics, providing innovative solutions across various sectors.

Products and Services
  • Life Science division offers specialized chemicals and advanced equipment for research and industry
  • Healthcare segment focuses on prescription medications and biopharmaceuticals for diverse medical conditions
  • Electronics division supplies essential materials for semiconductor and display manufacturing
Growth Outlook
  • Recent partnerships enhance the therapeutic pipeline, targeting critical cancer treatments
  • Continued investment in R&D supports innovation and market expansion
  • Strong demand in Life Science and Healthcare segments drives revenue growth
Financial Highlights
  • Q2 2026 revenue of €5.43 billion, reflecting a solid year-over-year increase
  • Net income for Q2 2026 reached €489 million, showcasing profitability
  • TTM gross profit margin stands at 58.69%, indicating operational efficiency
Merck KGaA has established itself as a leader in the healthcare and technology sectors, with a diverse portfolio that addresses critical needs in life sciences, healthcare, and electronics. The company's commitment to innovation is evident through its strategic partnerships and ongoing investments in research and development. Recent financial performance highlights a robust revenue stream and profitability, positioning Merck KGaA favorably for future growth. The company's strong gross profit margin reflects its operational efficiency, making it an attractive option for potential investors interested in the healthcare and technology industries.
AI Generated • Aug 19, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

62,136

CEO

Kai Beckmann, PhD

Website

www.merckgroup.com

Headquarters

Darmstadt, HE 64293, DE

MKGAF Financials

Key Financial Metrics (TTM)

Gross Margin

58.69%

Operating Margin

19.68%

Net Income Margin

11.22%

Return on Equity

8.08%

Return on Capital

10.02%

Return on Assets

4.50%

Earnings Yield

3.90%

Dividend Yield

1.58%

Payout Ratio

43.78%

Stock Overview

Market Cap

$70.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

434.78M

Volume

561

Avg. Volume

579.318

Financials (TTM)

Gross Profit

€12.41B

Operating Income

€4.16B

EBITDA

€6.92B

Operating Cash Flow

€4.50B

Capital Expenditure

-€1.57B

Free Cash Flow

€2.92B

Cash & ST Invst.

€1.95B

Total Debt

€12.28B

Merck KGaA Performance Analysis

Merck KGaA annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 23,365,261,0070.4%
20232023-12-31EUR 22,695,859,854-2.9%
20242024-12-31EUR 22,884,249,6410.8%
20252025-12-31EUR 23,815,251,9134.1%
Merck KGaA sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.2%
Q42025-12-31-1.3%
Q12026-03-31-1.8%
Q22026-06-305.3%
Merck KGaA annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 8.04-3.2%
20232023-12-31EUR 7.02-12.7%
20242024-12-31EUR 6.91-1.6%
20252025-12-31EUR 6.77-2.0%
Merck KGaA sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3038.0%
Q42025-12-31-64.7%
Q12026-03-31108.2%
Q22026-06-30-25.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€5.43B

+3.3%

Gross Profit

€3.16B

+4.4%

Gross Margin

58.26%

N/A

Market Cap

$70.96BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.14M

N/A

Employees

62,461

N/A

Net Income

€489.27M

-25.0%

EBITDA

€1.73B

+26.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€1.95B

+24.1%

Total Debt

€12.28B

+10.9%

Accounts Receivable

€4.90B

+12.3%

Inventory

€4.88B

+9.2%

Long Term Debt

€11.19B

+50.8%

Short Term Debt

€1.09B

-70.1%

Return on Assets

4.50%

N/A

Return on Invested Capital

9.34%

N/A

Free Cash Flow

€347.48M

+182.5%

Operating Cash Flow

€604.09M

+6.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IPSEYIpsen S.A.
$47.60+0.00%
WUXIFWuXi AppTec Co., Ltd.
$27.63+1.08%
CMXHFCSL Limited
$120.00+0.00%
SEMHFSiemens Healthineers AG
$47.59+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$120.60-0.01%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$47.03+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$71.17+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$39.02-0.01%

Questions About MKGAF

What is the current price of Merck KGaA?

Merck KGaA is trading at $163.21 per share.

What is the 52-week range for Merck KGaA?

Over the past 52 weeks, Merck KGaA has traded between $116.68 and $175.56.

How much debt does Merck KGaA have?

As of the most recent reporting period, Merck KGaA reported total debt of €14.06B.

How much cash does Merck KGaA have on hand?

Merck KGaA reported €2.24B in cash and cash equivalents in its most recent financial results.

What is Merck KGaA’s dividend yield?

Merck KGaA currently has a dividend yield of 1.58%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services